We previously showed that gliomas with mutations in isocitrate dehydrogenase 1 and 2 (IDHmut) methylate and suppress F3, the gene encoding Tissue Factor (TF), and that this contributes to the reduced aggressiveness of IDHmut gliomas compared to high TF-expressing GBM. The gene discussed is TF; the disease is central nervous system cancer.